Retroviridae Infections
-
Subject Areas on Research
- Alternative approaches for the application of ribozymes as gene therapies for retroviral infections.
- Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.
- CD4+Thy1- thymocytes with a Th-type 2 cytokine response.
- Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.
- Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
- Enhanced type 1 immunity after secondary viral challenge in mice primed as neonates.
- Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
- Expression of transfected DNA in avian cells can be enhanced in trans by retroviral infection.
- IFN-gamma production in response to neuropathogenic Cas-Br-M murine leukemia virus infection.
- Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus.
- Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections.
- In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteins.
- Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.
- Induction of protective CTL responses in newborn mice by a murine retrovirus.
- Is MMTV associated with human breast cancer? Maybe, but probably not.
- Local production of TGF beta1 inhibits cerebral edema, enhances TNF-alpha induced apoptosis and improves survival in a murine glioma model.
- Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees.
- Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV.
- Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
- Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells.
- Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.
- Prevalence of HTLV-I-associated T-cell lymphoma.
- Progress in vaccine development against SIV and HIV.
- Prospects for development of a vaccine against HTLV-III-related disorders.
- Prospects for treatment of human retrovirus-associated diseases.
- Retroviral E-DNA: persistence and gene expression in nondividing immune cells.
- Retroviruses and human cancer: evaluation of T-lymphocyte transformation by human T-cell leukemia-lymphoma virus.
- Strategies of antiretroviral therapy in adults.
- Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity.
- Ultraviolet-light-inactivated Cas-Br-M murine leukemia virus induces a protective CD8+ cytotoxic T lymphocyte response in newborn mice.
- Use of antiretroviral therapy in children and pregnant women.
-
Keywords of People
- Cianciolo, George James, Associate Professor in Pathology, Pathology
- Cunningham, Coleen Kathryn, Professor of Pediatrics, Pathology
- Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Immunology
- Weinhold, Kent James, Joseph W. and Dorothy W. Beard Professor of Experimental Surgery, in the School of Medicine, Immunology